Neo Performance Materials Reports Fourth Quarter 2025 Results

Executive Summary
- Neo Performance Materials reported Q4 2025 revenue of $120.3 M and full‑year 2025 revenue of $478.8 M, with Adjusted EBITDA of $75.6 M for the year – a 17% increase over 2024 and above prior guidance.
- The company declared a quarterly dividend of CAD 0.10 per share (record date March 19) and repurchased $4.0 M of common shares under its NCIB.
- Strategic highlights include the European Permanent Magnet facility reaching one‑millionth magnet production, a multi‑year MOU with Bosch, progress on heavy rare earth separation in Estonia, and completion of the divestiture of legacy Chinese rare‑earth assets.
Key Details
- Financial Performance
- Q4 2025 Adjusted EBITDA: $20.4 M (vs. $20.7 M Q4 2024).
- Full‑year 2025 Adjusted EBITDA: $75.6 M vs. $64.4 M in 2024; margin 15.8% (up 230 bps YoY).
- Revenue: Q4 2025 $120.3 M (down 10.7% YoY); FY 2025 $478.8 M (up 0.6% YoY).
- Adjusted Net Income FY 2025: $20.5 M ($0.49 EPS) vs. $1.9 M in 2024.
- Operating cash outflow for FY 2025: $54.0 M (driven by higher inventory, receivables, and a $12.5 M patent settlement).
-
Cash & equivalents end‑2025: $38.4 M; total debt $101.8 M.
-
Segment Results
- Magnequench: Adjusted EBITDA Q4 $6.0 M, FY $28.4 M (+11% YoY). Record bonded magnet shipments up 34.9% YoY.
- Chemicals & Oxides: Adjusted EBITDA Q4 $7.1 M, FY $23.4 M (+376% YoY) driven by portfolio optimization and pricing improvements. Emission catalyst volumes exceeded 10% growth target. Wastewater treatment volumes +13.9% Q4, +32.2% FY.
-
Rare Metals: Adjusted EBITDA Q4 $12.3 M, FY $43.2 M (down 29.3% Q4, 16.5% FY) reflecting hafnium price normalization; gallium business remains strong.
-
Strategic & Operational Highlights
- European Permanent Magnet facility: Grand opening Sep 2025; produced its one‑millionth magnet; early‑stage qualification complete; MOU with Bosch securing annual capacity.
- Facility showcased at 2025 G7 Summit. Planning for Phase 1b expansion to raise capacity from ~2,000 t/yr to 5,000 t/yr.
- Heavy rare earth separation demonstration line at Silmet (Estonia) on track for dysprosium & terbium production in 2026.
- Settlement of legacy IP litigation in Emission Catalyst business, reducing legal cost exposure.
-
Completed sale of Chinese rare‑earth separation assets (Mar 2025), simplifying portfolio and reallocating capital.
-
Dividends & Share Repurchases
- Quarterly dividend declared: CAD 0.10 per common share (record date Mar 19; payable Mar 26).
-
NCIB repurchase: $4.0 M of common shares during FY 2025.
-
Guidance & Outlook
- 2026 Adjusted EBITDA guidance: $75 M – $80 M.
- Anticipated commercial ramp‑up of European Permanent Magnet facility in 2026; potential Phase 1b expansion.
-
Continued focus on securing rare‑earth supply, expanding magnet capacity, and growing emission catalyst & wastewater treatment businesses.
-
Conference Call
- Date/Time: Thursday, March 19 2026 at 10:00 AM ET / 7:00 AM PT. Webcast link provided; replay available through April 14 2026.
Notable Quotes
“2025 was a year of meaningful execution and strategic progress for Neo… We delivered full‑year Adjusted EBITDA of $75.6 million, exceeding our previously issued guidance…” – Rahim Suleman, President & CEO
“Our European Permanent Magnet facility … is progressing through qualification milestones ahead of expected commercial production ramp‑up in 2026.” – Rahim Suleman
Materiality: Material – Positive (the release contains full‑year financial results that exceed guidance, dividend declaration, and significant strategic operational updates).